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Abstract
Background: Impairment of  peripheral skeletal muscle function is a common  phenomenon in patients with cystic fibrosis (CF) 
in addition to great clinical connotations, such as lack of  exercise tolerance and decrease of  health-related quality of  life. There is 
very limited data on the effects of  maximal exercise on muscle fatiguability and exercise capacity in children with cystic fibrosis. 
Objectives: The aim of  this study was to evaluate the effect of  progressive maximal exercise training of  the lower extremities 
on exercise capacity and muscle fatiguability in children with cystic fibrosis.
Study design: Between June and September 2017, eighteen children aged 8-12 years were recruited in this study. This study had 
two groups of  children; the CF group consisted of  nine children (6 males and 3 females) with cystic fibrosis and the control 
group consisted of   nine healthy age matched children (6 males and 3 females). The children underwent a progressive maximal 
cardiopulmonary exercise cycling test (CPET), muscle fatigue test, and magnetic resonance imaging (MRI) to measure a muscle 
cross-section area (CSA). Also, pulmonary functions were assessed.
Results: The findings of  this study showed that the CF children had less pulmonary functions, had a less exercise capacity, and 
had a higher breathing reserve index and oxygen desaturation when compared with healthy children (p<0.05). On the other 
hand, there was a non-significant difference in muscle fatiguability, muscle cross-section area, and maximal voluntary contraction 
between the CF and healthy children (p>0.05). 
Conclusion: This study indicates that progressive maximal exercise doesn’t affect muscle fatiguability, muscle cross-section area, 
and maximal voluntary contraction in CF children with moderate respiratory diseases but includes lower exercise capacity. CF 
children and healthy age matched children have similar responses to maximal exercise in muscle fatiguability, muscle cross-sec-
tion area, and maximal voluntary contractions but lower exercise capacity in the CF group.
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Introduction
Cystic fibrosis (CF) is an inherited lung disease character-
ized by the accumulation of  abnormal sticky, thick mu-
cus that lead to damage of  many body's organs including 
respiratory system damage and chronic complications in 
digestive system.1 CF is one of  the most common inher-
ited genetic disorder that causes progressive abnormal-
ities in the respiratory and digestive systems, leading to 
pancreatic dysfunction and chronic airway infection with 
extreme loss of  lung function and physical capacity. Al-
though chronic airway infection is considered as a main 
cause of  mortality in the disease end stages, pulmonary 
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function deteriorations didn’t clarify all characteristics of  
the disability accomplished in cystic fibrosis disease.1,2
Recently, many manifestations of  the cystic fibrosis dis-
ease indicate impairment of  peripheral muscle function 
as a main systemic manifestation of  CF disease.2 Also, the 
weakness of  skeletal muscles is related to consequential 
clinical complications such as decrease of  exercise capac-
ity3, decrease of  quality of  life (QOL).4 
Previous studies approved that peripheral muscle weak-
ness was reported in patients with cystic fibrosis. Strength 
and endurance of  skeletal muscle are reduced in CF pa-
tients compared with the control group, indicating dys-
function of  skeletal muscles.3,5 In addition, the strength 
of  the quadriceps muscle is associated with aerobic ca-
pacity and lung function. A considerable number of  CF 
patients with airway obstruction cannot do continuous 
exercise as they suffer from lower extremity fatigue, using 
a visual analogue scale.6 
Factors which affect exercise capacity in CF patients is 
generally unknown. Examining which causes conduce to 
the limitation of  exercise performance is especially prom-
inent in patients with CF. Actually, aerobic capacity is re-
lated to quality of  life and mortality in CF and can be 
used to investigate the treatment responses.7 Therefore, 
therapeutic plans intended to enhance aerobic capacity 
are important and pure rehabilitation has to direct to-
wards proper conducing factors.
Jeffery et al., early observed neuromuscular activity de-
teriorations in the quadriceps muscle after high-intensity 
aerobic exercise in patients with chronic obstructive pul-
monary disease.8 In spite the pathophysiology of  skeletal 
muscle is  plausibly not precisely alike, the current study 
could anticipate that similar deteriorations exist in other 
respiratory disease such as CF. 
Exercise training has several beneficial effects on many 
health measurements in CF and high scores of  exercise 
capacity are related to high QOL 4 and more endurance 
in this population.7,9 Despite the fact that impaired exer-
cise tolerance is a common characteristic of  CF disease, 
the accurate physiological mechanism abide to be clari-
fied, in special to improve pulmonary rehabilitation exer-
cise. It has been identified that respiratory reasons alone 
are not enough to clarify the lack of  exercise tolerance in 
patients with CF, particularly in subjects characterized by 
moderate respiratory disorder such as, bronchial dilations 
increase pulmonary function but do not increase aerobic 
tolerance in patients with cystic fibrosis. 
Many studies illustrated the effect of  maximal exercise 
training on muscle fatigue and exercise capacity in adults 
with CF but very limited studies explained the changes of  
exercise capacity and muscle fatiguability after maximal 
exercise training in children with CF.2,6,9,10 The hypothesis 
of  this study suggested that children with cystic fibrosis 
could lead to fatiguability of  the muscles exercised after 
maximum symptom-restricted exercise test in addition 
to their ventilatory limitations. Hence, this study aimed 
to evaluate the effect of  progressive maximal exercise 
training of  the lower extremities on exercise capacity and 
muscle fatiguability in children with cystic fibrosis..
Methods
Participants
This experimental controlled study was approved by the 
department of  physical therapy, Cairo University Hospi-
tals, according to the ethical standards of  human research. 
The protocol of  this study proceeded according to the 
guidelines in the Declaration of  Helsinki. A written con-
sent form was signed by caregivers or parents of  children 
before enrollment in the study. Each parent or caregiver 
was informed about the aim, procedures, and expected 
risks of  this study. Nine children (6 males and 3 females) 
aged 8-12 years with CF were obtained from Cairo Uni-
versity pediatric hospital. The CF children had moderate 
pulmonary disease [FEV1= 40-59% of  predicted value]. 
The children were stable clinically for two months before 
starting the study, received pancreatic enzymes supple-
ments and vitamins. Nine healthy age matched children 
were obtained for this study to constitute the control 
group (FEV1 > 80-100% of  predicted values, no cardio-
pulmonary restrictions, and no exercise training before 
examination). Children with severe medical illness such 
as cardiovascular disease, orthopedic problems and en-
docrine disorders that could affect physical exercise were 
excluded from the study. Demographic and clinical char-
acteristics of  the participated children in this study are 
shown in table 1.
Sample size
Power analysis was initially performed to calculate the 
sample size. The current study required a sample size of  
9 children for each group which was calculated by assum-
ing 80% power with 10% changes in muscle fatigability 
with standard deviation of  2 and significance level of  5% 
(two-sided test; α=0.05; power desired, 80%).
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Procedures
Assessment and measures
Cardiopulmonary exercise cycling test (CPET) was per-
formed using an electronic ergometer (Monark, 939 
Novo, Electronically Braked Cycle Ergometer, USA) 
and maximum oxygen uptake (VO2peak) was assessed. 
Quadriceps cross-section area (CSA) in random request 
within 2 days was measured by magnetic resonance im-
aging (MRI) using (Centauri MPF 3000 0.3T, XBO medi-
cal systems Ltd., Baotou, China). Muscle fatiguability and 
maximal voluntary contraction (MVC) of  the quadriceps 
muscle was assessed by digital Electromyography (EMG) 
using (Dantec Keypoint Focus - 6 channels, Natus medi-
cal incorporated, Pleasanton, USA).
Intervention (CPET Protocol)
CPET was performed on a cycle ergometer as previously 
described11 and according to the international standards 
of  the American thoracic society.12 Each child was in-
structed for warming up for 2-3 minutes of  constant-state 
riding a bicycle (60-70 rpm) to calculate the child’s ability 
to cycling and to prepare the child to the cycle test pro-
gram. During the warming up, the maximum heart rate 
(HRmax) was 100 to 115 bpm. After warm up, each child 
was yielded to sub-maximal constant-state pedaling for 
5 minutes  with steady cycling speed (60-70 rpm), pro-
viding more reinforcement. The sub-maximal workload 
(1.75 × warm-up load) had a HRmax of  60%-70% of  the 
maximal calculated HR.13 During CPET, if  the heart rate 
was not (60%-70%) of  the HRmax,the resistance (5-10 
W) was increased or decreased. In between the progres-
sive maximal cycling exercise test, there was one minute 
rest. The examiner determined the workload of  the sub-
maximal test according to the initial load, and increased 
the load every minute gradually from 3 to 10 W, based 
on child’s ability. The needed cycle pedaling was 60 to 
70 rpm. All children were instructed to execute exercise 
training to a symptom-restricted maximum. Oxygen up-
take (VO2) and carbon dioxide production (VCO2) were 
recorded breath by breath. Respiratory exchange ratio 
and predicted maximum heart rate were measured to ap-
prove the maximal feature of  the cycling exercise. Muscle 
fatigability was assessed following CPET through isomet-
ric contraction of  the quadriceps muscle. 
Data analysis
Statistical analysis was applied in the form of  means 
and standard deviations. Inferential statistics analyzed all 
measurement changes using unpaired t-test between CF 
and control groups and paired t-test to assess the chang-
es within the group. Mann-Whitney U test was used to 
analyze the gender's difference between the two groups. 
Analysis was done using SPSS version 19.0 (SPSS, Chica-
go, IL) with statistical significance at p-value ≤ 0.05.
Results 
Between June and September 2017, eighteen children 
aged 8-12 years were recruited in this study. This study 
had two groups of  children; the CF group consisted of  
nine children (6 males and 3 females) with cystic fibro-
sis and the control group consisted of   nine healthy age 
matched children (6 males and 3 females). In demograph-
ic data, there were no statistically significant differences 
between the CF and control groups in their ages, heights, 
weights, BMI (p>0.05) while in pulmonary function, 
there were statistically significant differences between 
the two groups in their forced expiratory volume in one 
second (FEV1) and forced vital capacity (FVC). The de-
mographic and pulmonary function of  the participating 
children are demonstrated in table 1. 
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Table 1 Demographic and baseline characteristics of the children participated in 
the study 
Items CF group (n=9) Control group (n=9) p-value 
Sex (M/F) 6/3 6/3 1.000b 
Age (yrs) 11±0.3 12±0.4 0.557a 
Height (cm) 144±5.3 146±4.7 0.409a 
Weight (kg) 43.4±3.7 45.7±3.5 0.194a 
BMI (kg/m2) 20.9±2.3 21.4±2.8 0.684a 
Pulmonary functions 
FEV1 (L/ % pred) 2.3±0.7 (56.4) 4.1±0.8 (102.7) 0.001a 
FVC (L/ % pred) 4.0±0.8 (67.5) 5.2±1.2 (103.4) 0.023a 
Abbreviations: Data was applied in form of mean±SD; a p-value of independent t-test; b p-
value of Mann-Whitney U test; CF, cystic fibrosis; M/F, male/female; BMI, body mass index; 
FEV1, forced expiratory volume in one second; FVC, forced vital capacity. 
 
According to the children criteria in this study, the CF 
and control groups performed the cardiopulmonary ex-
ercise test (CPET) through a maximal incremental cycling 
exercise. The CF children had less value of  peak pow-
er output, VO2 peak, maximum minute ventilation, and 
maximum heart rate when compared with the control 
group (p<0.05). Moreover the CF children had higher 
values of  the breathing reserve index at maximal exercise 
and oxygen desaturation when compared with the con-
trol group (p<0.05) but there was a non-significant dif-
ference in muscle fatigue measure, cross-section area, and 
maximal voluntary contraction between the two groups 
as demonstrated in table 2.
Table 2 The Post- cardiopulmonary exercise test (CPET) in the CF and control 
groups 
CPET variables CF group (n=9) Mean± SD 
Control  group (n=9) 
Mean± SD 
P-value 
Peak power output (W) 139.4±21.5 237.2±42.3 0.001 
VO2peak (L) 1.8±0.6 2.9±0.8 0.004 
MMV (L) 87.4±18.2 117.5±25.3 0.011 
BRImax 0.97±0.11 0.88±0.06 0.045 
HRmax (bpm) 161±11 178±12 0.006 
Oxygen desaturation (%) 2.7±1.2 0.7±0.3 0.002 
Muscle fatigue 82±13 79±11 0.604 
CSA (cm2) 35.2±8.3 42.3±9.7 0.114 
MVC (Nm) 112±37 141±45 0.154 
Abbreviations: SD, standard Deviation; P, probability; CF, cystic fibrosis; VO2peak, peak 
oxygen uptake; MMV, maximum minute ventilation; BRImax, breathing reserve index; HRmax, 
maximum heart rate; CSA, cross-section area; MVC, maximal voluntary contraction. 
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Discussion
The main findings of  this study, the stable CF children 
had less pulmonary functions (FEV1, FVC), had a less 
exercise capacity (peak power output, peak oxygen up-
take, maximum minute ventilation, maximum heart rate), 
and had a higher breathing reserve index and oxygen 
desaturation when compared with healthy children. On 
the other hand, there was a non-significant difference 
in muscle fatiguability, cross-section area, and maximal 
voluntary contraction between the CF and healthy chil-
dren. These findings didn’t conduct the hypothesis of  
this study, which supposed that CF children could suf-
fer from extreme fatiguability of  the muscles exercised 
after maximum symptom-restricted exercise test. Many 
studies have evaluated muscle endurance in patients with 
CF including adults and children. The most studied mus-
cle was the quadriceps muscle, as it has a consequential 
functional activity. Previous studies documented consid-
erable reduction in maximal voluntary contraction of  the 
quadriceps muscle3,14 whereas the other studies did not 
approve these reports.15 
The present study results may clarify some of  the differ-
ences reported in the previous studies and can give signif-
icant perceptions respecting the underlying mechanisms 
of  muscle dysfunction in children with  CF. This study 
found a non-significant decrease of  quadriceps muscle 
fatigue in children with CF. This inclination may be asso-
ciated with decreases in contractile function and volun-
tary activation of  the muscle also inclined to be decreased 
in children with CF. Though, all of  these delicate non-sig-
nificant discrepancies extinct when related to muscle 
cross-section area indicating that the decrease of  muscle 
strength reported in earlier studies may be associated with 
decrease of  muscle mass more than changes of  stimula-
tion contraction connection. Several causes may possibly 
lead to decrease in CSA the muscle in children with CF, 
like alterations of  the nutrition status14, expressed exac-
erbations16, medication17, physical inactivity3, or inflam-
mation.18 
According to this study results, it was reported that a deli-
cate inclination for decreased CSA of  the quadriceps mus-
cle  in children with CF exists, which is coherent with the 
results of  previous studies in more severe children.18 The 
CF children in the present study characterized by good 
conditions, such as stable clinically, proper nutrition, and 
no corticosteroids therapy. Also, the level of  systemic in-
flammation is associated with the level of  airway impedi-
ment19, the role of  inflammation was apparently restricted 
in the children of  this study as they had a moderate pul-
monary disease, moreover illustrating the disappearing of  
the considerable decrease of  CSA in CF children in this 
study. Early study explained that children with CF are less 
included in moderate to high-intensity exercise in spite 
of  same commitment in low-intensity exercise.3 There-
fore, in spite of  similar worldwide physical activity level, 
it may believe that the possible delicate decreases of  CSA 
of  the quadriceps muscle and contractile variables are in 
apportion result from lower obligation of  this study chil-
dren in maximal intensity or strengthening exercise than 
healthy children. Muscle fatigue and endurance assess-
ment were very restricted in children with CF. Previous 
studies assessed the endurance of  the quadriceps muscle 
in adults with CF.5,20 It was documented that the time of  
endurance was decreased during isometric contraction in 
adults with CF at 50% maximum voluntary contraction 
maintained up to fatigue20, and another study document-
ed fewer number in women knee flexions, not in men, 
when compared with age-matched healthy adults.5 These 
studies had many limitations; adults were not subjected 
to a similar level of  physical activity which cannot be ig-
nored that low level of  usual physical activity could result 
in decreased muscle endurance in patients with CF. Also, 
these assessments of  muscle endurance were complete-
ly dependent on physical exertion and therefore greatly 
affected by collaboration and inspiration of  the subject. 
This limitation can illustrate the cause of  higher changes 
of  endurance time in adults with CF than healthy adults.20 
The present study established similar decreases in max-
imum voluntary contraction during the task of  muscle 
fatigue in CF and healthy subjects, indicating non-signifi-
cant differences in muscle fatigue in the two groups. This 
similarity may be related to similarity of  muscle fatigue 
development. 
Therefore, the skeletal muscle in patients with cystic fi-
brosis should exhibit sufficient capability for training in 
response to proper excitation, as recently reported.21 Be-
cause muscle mass is associated with a mortality rate in 
patients with CF2, the findings of  this study may support 
the systematic integration of  allot effectiveness rehabili-
tation methods aspiration to improve muscle mass, as it 
may have a beneficial  impact on aerobic capacity, quality 
of  life, morbidity, mortality.
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Recently, one study established reduced intramuscular ac-
idosis and concentrations of  ATP in the thigh muscles 
of  children with CF when compared with matching-age 
healthy subjects and ciliary dyskinesia patients.22 Even 
so, patients with CF accomplished similar work rates 
throughout a 30-s, 90-s with 5-min CPET compared with 
matching-age healthy subjects and ciliary dyskinesia pa-
tients. So, it is suitable that the intrinsic changes in mus-
cles of  children with CF, if  these changes survive, haven’t 
functional outcomes such as decrease of  muscle strength 
and increase of  muscle fatigue. On the other hand, Sel-
vadurai et al23 reported an association between genotype 
and exercise capacity, pulmonary functions. This report 
would necessitate more assessments joining evaluations 
at the levels of  the cell with muscle fatigue measurement 
to find out, whether a presented alteration or particular 
mutation such as decrease of  genotype manifestation in 
the myocytes that could result in  muscle fatigue.24 
Limitations
The test of  muscle fatiguability through isometric con-
traction is not necessary to demonstrate the activity daily 
life of  the children. By contrast, the present study ap-
proved that VO2 peak demonstrated throughout cycling 
exercise test was related significantly to the strength and 
endurance of  the quadriceps muscle. Therefore, the func-
tion of  the peripheral muscle may illustrate particularly 
the decreased exercise capacity in children with CF. Al-
though, the smaller the difference of  VO2peak between 
the two groups was decreased when standardized to CSA 
of  the quadriceps muscle in  children with CF. The de-
crease of  the breathing reserve index at maximum cycling 
exercise test in children with CF reflects that, beside mus-
cle strength, pulmonary agents have an important role 
concerning exercise restriction of  whole body in children 
with moderate pulmonary disease.
Conclusion
The findings of  this study indicate that progressive max-
imal exercise doesn’t affect muscle fatiguability, muscle 
cross section area, and maximal voluntary contraction in 
CF children with moderate respiratory diseases but in-
cludes lower exercise capacity. CF children and healthy 
age matched children have similar responses to maximal 
exercise in muscle fatiguability, muscle cross-section area, 
and maximal voluntary contractions but lower exercise 
capacity in the CF group.
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